September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Characterization of ex-vivo transscleral diffusion of dexamethasone sodium phosphate and triamcinolone acetonide in solution and a dry formulation
Author Affiliations & Notes
  • Pamela Peidrienne Ko
    Ophthalmology, Eye Care for Animals, San Diego, California, United States
    Ophthalmology, 3TOphthalmics , Irvine, California, United States
  • Jonathan Moreno
    Ophthalmology, 3TOphthalmics , Irvine, California, United States
  • robert brito
    Ophthalmology, 3TOphthalmics , Irvine, California, United States
  • Ricardo A P De Carvalho
    Ophthalmology, 3TOphthalmics , Irvine, California, United States
  • Footnotes
    Commercial Relationships   Pamela Ko, None; Jonathan Moreno, None; robert brito, None; Ricardo De Carvalho, None
  • Footnotes
    Support  This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0030. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5394. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Pamela Peidrienne Ko, Jonathan Moreno, robert brito, Ricardo A P De Carvalho; Characterization of ex-vivo transscleral diffusion of dexamethasone sodium phosphate and triamcinolone acetonide in solution and a dry formulation. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5394.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate and compare the ex-vivo (rabbit and porcine) transscleral diffusion permeability profile of dexamethasone sodium phosphate (Dex SP) and triamcinolone acetonide (TA) in solution and lyophilized dry form.

Methods : The sclerae were harvested from fresh porcine and albino rabbit globes. The effect of solution and a lyophilized formulation on the transscleral permeability was investigated using Franz-type vertical diffusion cells after delivery of Dex SP and TA at 6 and 9 mg/ml concentrations in the donor side and its quantification by HPLC in the recipient side. The transscleral flux and permeability coefficient were calculated. Permeability parameters were determined and compared with ANOVA (p<0.05).

Results : It was demonstrated that both solutions and lyophilized formulations of Dex SP and TA at 6 and 9 mg/mL could diffuse across the sclera and that permeation decreased over time in porcine and rabbit. The flux of Dex SP in solution and lyophilized formulation at 6 mg were 2.22 and 6.92 ug/cm2Hr respectively in porcine. After 48 hours, in average 62.8% and 42.8% of the initial 6 mg solution and dry Dex SP, respectively had been recovered in the recipient side (p = 0.00014).

The flux of TA in porcine sclera after exposure to 6 mg in solution and lyophilized formulations was 0.1568 and 0.0089 ug/cm2Hr, respectively, and the permeability coefficients were 7.29 x 10-9 and 4.23 x 10-10 cm/s. After 48 hours of diffusion, the recovery of TA 6 mg were 0.8% and 0.2%, respectively, for solution and lyophilized forms of TA (p = 0.0131). The majority of the lyophilized dry form was found in the donor chambers with 60.9% of total recovery of TA 6 mg.

Conclusions : We have shown that transscleral diffusion of hydrophilic and lipophilic steroidal anti-inflammatory drugs in solution and dry-lyophilized formulations. Both formulations were able to provide drug permeation through the sclerae in different species. It indicates that soluble and insoluble drugs can benefit from the use of liquid and dry formulations for episcleral delivery.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×